Cargando…

Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study

PURPOSE: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) often occur concomitantly, presenting diagnostic and therapeutic challenges for clinicians. We examined the characteristics of patients prescribed adequate versus inadequate therapy within 3 months after newly diagnosed com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostikas, Konstantinos, Rhee, Chin Kook, Hurst, John R, Agostoni, Piergiuseppe, Cao, Hui, Fogel, Robert, Jones, Rupert, Kocks, Janwillem W H, Mezzi, Karen, Wan Yau Ming, Simon, Ryan, Ronan, Price, David B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276330/ https://www.ncbi.nlm.nih.gov/pubmed/32581622 http://dx.doi.org/10.2147/POR.S250451

Ejemplares similares

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
por: Anzueto, Antonio R, et al.
Publicado: (2017)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
por: Vogelmeier, Claus F., et al.
Publicado: (2019)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study
por: Anzueto, Antonio R., et al.
Publicado: (2018)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study
por: Wedzicha, Jadwiga A., et al.
Publicado: (2019)

The Perception of Physicians on Gender-Specific Differences in the Diagnosis of COPD: Results from a Questionnaire-Based Survey
por: Raherison-Semjen, Chantal, et al.
Publicado: (2021)

Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021)

Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study
por: Price, David B., et al.
Publicado: (2016)

COPD management: role of symptom assessment in routine clinical practice
por: van der Molen, Thys, et al.
Publicado: (2013)

Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ)
por: Tsiligianni, Ioanna G, et al.
Publicado: (2012)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
por: Rodrigo, Gustavo J, et al.
Publicado: (2017)

Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
por: Price, David B., et al.
Publicado: (2019)

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD
por: Ming, Simon Wan Yau, et al.
Publicado: (2020)

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
por: van Boven, Job FM, et al.
Publicado: (2016)

Relationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD—A Systematic Scoping Review
por: Leving, Marika T., et al.
Publicado: (2022)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
por: Voorham, Jaco, et al.
Publicado: (2019)

Impact of the UK lockdown on people at risk of COPD
por: Donaldson, Gavin C., et al.
Publicado: (2021)

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial
por: Halpin, David M G, et al.
Publicado: (2022)

Putting health status guided COPD management to the test: protocol of the MARCH study
por: Kocks, Janwillem, et al.
Publicado: (2013)

Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG
por: Tsiligianni, Ioanna, et al.
Publicado: (2016)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Towards Rational Prescription of Common Inhaler Medication in the Multimorbid COPD Patient
por: Tsiligianni, Ioanna, et al.
Publicado: (2021)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study
por: Halpin, David M.G., et al.
Publicado: (2023)

Little agreement in GOLD category using CAT and mMRC in 450 primary care COPD patients in New Zealand
por: Holt, Shaun, et al.
Publicado: (2014)

"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD
por: Kostikas, Konstantinos, et al.
Publicado: (2010)

Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD
por: Kostikas, Konstantinos, et al.
Publicado: (2018)

Socio-economic factors, gender and smoking as determinants of COPD in a low-income country of sub-Saharan Africa: FRESH AIR Uganda
por: van Gemert, Frederik, et al.
Publicado: (2016)

Hypercoagulable State in COPD-A Comprehensive Literature Review
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study)
por: Leving, Marika, et al.
Publicado: (2021)

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis
por: Vogelmeier, Claus, et al.
Publicado: (2016)

Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD
por: Westerik, Janine A. M., et al.
Publicado: (2017)

The impact of recency and adequacy of historical information on sepsis predictions using machine learning
por: Zargoush, Manaf, et al.
Publicado: (2021)

Pulmonary biomarkers in COPD exacerbations: a systematic review
por: Koutsokera, Angela, et al.
Publicado: (2013)

Prevalence of Asthma Characteristics in COPD Patients in a Dutch Well-Established Asthma/COPD Service for Primary Care
por: Baron, Anna Jetske, et al.
Publicado: (2020)

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
por: Brusselle, Guy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_853eep8sndp9ks94dfkof2lk1f